Skip to main content

TUDOR INVESTMENT CORP ET AL

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 923093 STAMFORD, CT

Position in VRTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$14,989,324
+$14,989,324 QoQ
Shares Held
30,176
Ownership
0.012%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#299
of 1,735 holders
Holding Since
Mar 2020
16 quarters on record
Voting authority Sole 50% Shared 50% None 0%

Common Shares in VRTX Over Time

Shares Held

Position Value (USD)

Derivatives in VRTX

reported options exposure · as of Jun 30, 2026
CallValue
$2,682,342
CallShares
5,400
PutValue
$596,076
PutShares
1,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TUDOR INVESTMENT CORP ET AL holds $411,209,149 across 107 Biotechnology names. VRTX ranks #9 (3.6% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in VRTX

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $14,989,324 30,176
2026-06-30 $2,682,342 5,400
2026-06-30 $596,076 1,200
2026-03-31 $1,027,042 2,300
2026-03-31 $714,464 1,600
2025-12-31 $5,485,656 12,100
2025-12-31 $2,557,403 5,641
2025-09-30 $6,853,700 17,500
2025-09-30 $20,120,113 51,374
2025-06-30 $578,760 1,300
2025-06-30 $4,184,880 9,400
2024-12-31 $3,810,750 9,463
2024-12-31 $483,240 1,200
2024-12-31 $483,240 1,200
2024-03-31 $9,835,357 23,529
2023-12-31 $10,743,930 26,405
2023-09-30 $11,598,867 33,355
2022-12-31 $2,188,952 7,580
2021-09-30 $5,379,664 29,658
2021-03-31 $3,709,431 17,262
2020-12-31 $10,943,251 46,303
2020-09-30 $1,551,900 5,703
2020-06-30 $2,260,643 7,787
2020-03-31 $2,468,017 10,372